Results 61 to 70 of about 9,655 (184)

Designing Annotations in Visualization: Considerations from Visualization Practitioners and Educators

open access: yesComputer Graphics Forum, EarlyView.
Abstract Annotation is a central mechanism in visualization design that enables people to communicate key insights. Prior research has provided essential accounts of the visual forms annotations take, but less attention has been paid to the decisions behind them.
Md Dilshadur Rahman   +3 more
wiley   +1 more source

Association of Global Longitudinal Strain With Left Ventricular Remodeling and Left Ventricular Hypertrophy in Patients With Acute Myocardial Infarction After PCI: A Small Single‐Center Prospective Observational Study

open access: yesHealth Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background and Aims Among patients with acute myocardial infarction undergoing PCI, subsequent structural alterations of the left ventricle, including left ventricular remodeling (LVR) and left ventricular hypertrophy (LVH), may contribute to later heart failure.
Bing Wang   +4 more
wiley   +1 more source

Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention

open access: yesJournal of Interventional Cardiology, 2019
Objective. Coronary slow/no reflow is not rare after successfully undergoing primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI), and shock index (SI) is an important factor for adverse cardiovascular ...
Qingcheng Wang   +5 more
doaj   +1 more source

Ischemia–Reperfusion Injury: Molecular Mechanisms and Therapeutic Interventions

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Multiorgan ischemia–reperfusion injury begins with ischemia‐induced ATP depletion and ionic imbalance, followed by reperfusion‐triggered mitochondrial ROS/RNS bursts, regulated cell death, and DAMP release. Sterile inflammation converges on endothelial–immune–coagulation crosstalk, where NETs drive immunothrombosis, no‐reflow, and remote organ injury ...
Peng An   +4 more
wiley   +1 more source

Association of Pre-PCI Blood Pressure and No-Reflow in Patients with Acute ST-Elevation Coronary Infarction

open access: yesGlobal Heart
Background: Previous studies have established blood pressure (BP) as a pivotal factor influencing no-reflow following primary percutaneous coronary intervention (PCI) in patients with ST-elevation acute coronary infarction (STEMI).
Xiaobo Li   +7 more
doaj   +1 more source

Predictive value of preoperative D-dimer combined with activated partial thromboplastin time for slow/no-reflow phenomenon in emergency percutaneous coronary intervention

open access: yesDi-san junyi daxue xuebao, 2019
Objective To investigate the predictive value of D-dimer combined with activated partial thromboplastin time (APTT) for slow/no-reflow of percutaneous coronary intervention (PCI) in patients with acute coronary syndrome(ACS).
LIU Ting   +4 more
doaj   +1 more source

Sustainable Photovoltaics: Optimising Material Consumption, Cost and Environmental Performance Through Smart Sustainability Approaches for Crystalline Silicon Solar Photovoltaics

open access: yesSolar RRL, Volume 10, Issue 11, 15 June 2026.
A sustainability framework shows that photovoltaics can simultaneously improve material security, reduce costs, and improve environmental performance. Updated learning curves reveal declining material intensity and emissions alongside rising energy return on investment, EROI (> 25).
Moonyong Kim   +8 more
wiley   +1 more source

Safety and Efficacy of Intracoronary Vasodilators in the Treatment of No-Reflow after Primary Percutaneous Intervention in Patients with Acute ST-Elevation Myocardial Infarction: A Literature Review [PDF]

open access: yesPatient Safety and Quality Improvement Journal, 2016
Introduction: The investigation of no-reflow phenomenon after Percutaneous Coronary Intervention (PCI) in patients with acute ST-segment Elevation Myocardial Infarction (STEMI) has therapeutic implications.
Mostafa Dastani, Somaye Alirezaei
doaj  

Anticoagulants and No-Reflow [PDF]

open access: yesAngiology, 2019
Sefa Ünal   +10 more
openaire   +2 more sources

A Practical Method for No-Reflow Treatment

open access: yesCase Reports in Cardiology, 2016
No-reflow is an undesirable result of percutaneous coronary interventions. Vasoactive drug administration at the distal part of the coronary artery is suggested as a therapeutic option for no-reflow treatment.
Mustafa Cetin   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy